Cargando…

A Pharmaceutical Bioethics Consultation Service: Six-Year Descriptive Characteristics and Results of a Feedback Survey

Background: Bioethics consultations are conducted in varied settings, including hospitals, universities, and other research institutions, but there is sparse information about bioethics consultations conducted in corporate settings such as pharmaceutical companies. The purpose of this article is to...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Campen, Luann E., Allen, Albert J., Watson, Susan B., Therasse, Donald G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688593/
https://www.ncbi.nlm.nih.gov/pubmed/26740962
http://dx.doi.org/10.1080/23294515.2014.957363
_version_ 1782406747457060864
author Van Campen, Luann E.
Allen, Albert J.
Watson, Susan B.
Therasse, Donald G.
author_facet Van Campen, Luann E.
Allen, Albert J.
Watson, Susan B.
Therasse, Donald G.
author_sort Van Campen, Luann E.
collection PubMed
description Background: Bioethics consultations are conducted in varied settings, including hospitals, universities, and other research institutions, but there is sparse information about bioethics consultations conducted in corporate settings such as pharmaceutical companies. The purpose of this article is to describe a bioethics consultation service at a pharmaceutical company, to report characteristics of consultations completed by the service over a 6-year period, and to share results of a consultation feedback survey. Methods: Data on the descriptive characteristics of bioethics consultations were collected from 2008 to 2013 and analyzed in Excel 2007. Categorical data were analyzed via the pivot table function, and time-based variables were analyzed via formulas. The feedback survey was administered to consultation requesters from 2009 to 2012 and also analyzed in Excel 2007. Results: Over the 6-year period, 189 bioethics consultations were conducted. The number of consultations increased from five per year in 2008 to approximately one per week in 2013. During this time, the format of the consultation service was changed from a committee-only approach to a tiered approach (tailored to the needs of the case). The five most frequent topics were informed consent, early termination of a clinical trial, benefits and risks, human biological samples, and patient rights. The feedback survey results suggest the consultation service is well regarded overall and viewed as approachable, helpful, and responsive. Conclusions: Pharmaceutical bioethics consultation is a unique category of bioethics consultation that primarily focuses on pharmaceutical research and development but also touches on aspects of clinical ethics, business ethics, and organizational ethics. Results indicate there is a demand for a tiered bioethics consultation service within this pharmaceutical company and that advice was valued. This company's experience indicates that a bioethics consultation service raises awareness about bioethics, empowers employees to raise bioethical concerns, and helps them reason through challenging issues.
format Online
Article
Text
id pubmed-4688593
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Routledge
record_format MEDLINE/PubMed
spelling pubmed-46885932016-01-04 A Pharmaceutical Bioethics Consultation Service: Six-Year Descriptive Characteristics and Results of a Feedback Survey Van Campen, Luann E. Allen, Albert J. Watson, Susan B. Therasse, Donald G. AJOB Empir Bioeth Article Background: Bioethics consultations are conducted in varied settings, including hospitals, universities, and other research institutions, but there is sparse information about bioethics consultations conducted in corporate settings such as pharmaceutical companies. The purpose of this article is to describe a bioethics consultation service at a pharmaceutical company, to report characteristics of consultations completed by the service over a 6-year period, and to share results of a consultation feedback survey. Methods: Data on the descriptive characteristics of bioethics consultations were collected from 2008 to 2013 and analyzed in Excel 2007. Categorical data were analyzed via the pivot table function, and time-based variables were analyzed via formulas. The feedback survey was administered to consultation requesters from 2009 to 2012 and also analyzed in Excel 2007. Results: Over the 6-year period, 189 bioethics consultations were conducted. The number of consultations increased from five per year in 2008 to approximately one per week in 2013. During this time, the format of the consultation service was changed from a committee-only approach to a tiered approach (tailored to the needs of the case). The five most frequent topics were informed consent, early termination of a clinical trial, benefits and risks, human biological samples, and patient rights. The feedback survey results suggest the consultation service is well regarded overall and viewed as approachable, helpful, and responsive. Conclusions: Pharmaceutical bioethics consultation is a unique category of bioethics consultation that primarily focuses on pharmaceutical research and development but also touches on aspects of clinical ethics, business ethics, and organizational ethics. Results indicate there is a demand for a tiered bioethics consultation service within this pharmaceutical company and that advice was valued. This company's experience indicates that a bioethics consultation service raises awareness about bioethics, empowers employees to raise bioethical concerns, and helps them reason through challenging issues. Routledge 2015-04-03 2014-10-10 /pmc/articles/PMC4688593/ /pubmed/26740962 http://dx.doi.org/10.1080/23294515.2014.957363 Text en © 2015 Eli Lilly and Company. Published with license by Taylor & Francis This is an Open Access article. Non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly attributed, cited, and is not altered, transformed, or built upon in any way, is permitted. The moral rights of the named author(s) have been asserted.
spellingShingle Article
Van Campen, Luann E.
Allen, Albert J.
Watson, Susan B.
Therasse, Donald G.
A Pharmaceutical Bioethics Consultation Service: Six-Year Descriptive Characteristics and Results of a Feedback Survey
title A Pharmaceutical Bioethics Consultation Service: Six-Year Descriptive Characteristics and Results of a Feedback Survey
title_full A Pharmaceutical Bioethics Consultation Service: Six-Year Descriptive Characteristics and Results of a Feedback Survey
title_fullStr A Pharmaceutical Bioethics Consultation Service: Six-Year Descriptive Characteristics and Results of a Feedback Survey
title_full_unstemmed A Pharmaceutical Bioethics Consultation Service: Six-Year Descriptive Characteristics and Results of a Feedback Survey
title_short A Pharmaceutical Bioethics Consultation Service: Six-Year Descriptive Characteristics and Results of a Feedback Survey
title_sort pharmaceutical bioethics consultation service: six-year descriptive characteristics and results of a feedback survey
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688593/
https://www.ncbi.nlm.nih.gov/pubmed/26740962
http://dx.doi.org/10.1080/23294515.2014.957363
work_keys_str_mv AT vancampenluanne apharmaceuticalbioethicsconsultationservicesixyeardescriptivecharacteristicsandresultsofafeedbacksurvey
AT allenalbertj apharmaceuticalbioethicsconsultationservicesixyeardescriptivecharacteristicsandresultsofafeedbacksurvey
AT watsonsusanb apharmaceuticalbioethicsconsultationservicesixyeardescriptivecharacteristicsandresultsofafeedbacksurvey
AT therassedonaldg apharmaceuticalbioethicsconsultationservicesixyeardescriptivecharacteristicsandresultsofafeedbacksurvey
AT vancampenluanne pharmaceuticalbioethicsconsultationservicesixyeardescriptivecharacteristicsandresultsofafeedbacksurvey
AT allenalbertj pharmaceuticalbioethicsconsultationservicesixyeardescriptivecharacteristicsandresultsofafeedbacksurvey
AT watsonsusanb pharmaceuticalbioethicsconsultationservicesixyeardescriptivecharacteristicsandresultsofafeedbacksurvey
AT therassedonaldg pharmaceuticalbioethicsconsultationservicesixyeardescriptivecharacteristicsandresultsofafeedbacksurvey